Dr. Henry Mahncke is the CEO of Posit Science. He joined Posit Science at its inception in 2003 as Vice President of Research & Outcomes, where he led the first large-scale clinical trials of a publicly available cognitive training program. He became CEO of Posit Science in 2011. Previously, he served as consultant at McKinsey focused on health care and video games, and then as a science and technology advisor to the British government. Dr. Mahncke earned his PhD in Neuroscience at the University of California, San Francisco, where he studied brain plasticity with Dr. Michael Merzenich.